OverviewChartNewsTraderScreen

BVT Put 170 PGR 20.09.2024/  DE000VM8A0Q3  /

Frankfurt Zert./VONT
2024-08-05  8:01:04 PM Chg.+0.063 Bid9:54:59 PM Ask9:54:59 PM Underlying Strike price Expiration date Option type
0.171EUR +58.33% -
Bid Size: -		 -
Ask Size: -		 Progressive Corporat... 170.00 USD 2024-09-20 Put
TeleTrader 07-29 Putin congratulates Maduro on election victory
TeleTrader 07-27 G20 agrees to work together to tax billionaires
TeleTrader 07-25 Nikki Haley not surprised by Biden's presidential race exit
TeleTrader 07-15 Syrians head to polls for parliamentary elections
TeleTrader 07-13 Progressive Caucus meets with Biden
TeleTrader 07-11 Peskov: NATO nears Russia's borders, could provoke response
TeleTrader 07-08 Lula proud of France's fight against 'extremism'
TeleTrader 07-05 Trudeau, Albanese welcome Labour Party's landslide victory
GlobeNewswire 06-25 argenx Highlights Breadth of Autoimmune Pipeline with New Multifocal Motor Neuropathy Data at 2024 P...
GlobeNewswire 06-25 AskBio Initiates Recruitment to its Phase 2 Parkinson’s Disease Trial
GlobeNewswire 06-24 Enlivex Announces the Dosing of the First Patient in a Randomized, Placebo-Controlled Phase I/II Tri...
GlobeNewswire 06-24 4DMT Announces FDA Clearance of IND Application for 4D-175 Genetic Medicine for the Treatment of Geo...
GlobeNewswire 06-24 Entrada Therapeutics Reports Positive Preliminary Data in Healthy Volunteers from Phase 1 ENTR-601-4...
GlobeNewswire 06-19 Opthea A$55.0m (US$36.9m¹) Retail Entitlement Offer Opens
GlobeNewswire 06-18 Afamelanotide in fair-skinned Parkinson’s patients
GlobeNewswire 06-14 Progressive Reports May 2024 Results
GlobeNewswire 06-13 Dyne Therapeutics Presents New Preclinical Data for its Facioscapulohumeral Muscular Dystrophy Progr...
GlobeNewswire 06-12 Ultragenyx Announces Plans to File for Accelerated Approval of UX111 for the Treatment of Sanfilippo...
GlobeNewswire 06-12 Belite Bio Receives Sakigake (Pioneer Drug) Designation of Tinlarebant for Stargardt Disease in Japa...
GlobeNewswire 06-11 Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D ...
GlobeNewswire 06-11 Processa Pharmaceuticals Announces Positive Efficacy Results from Preliminary Evaluation of Phase 1b...
GlobeNewswire 06-11 FDA Accepts Tiziana Life Sciences Fast Track Designation Submission for Treatment of Multiple Sclero...
GlobeNewswire 06-10 LifeWallet’s Proprietary Data System is Instrumental in Class Certification Against USAA Property an...
GlobeNewswire 06-10 SYFOVRE® (pegcetacoplan injection) Preserved Visual Function at 36 Months in GALE Extension Study in...
TeleTrader 06-09 EP updated results, EPP with 189 seats